Assessment of tuberculosis infection during treatment with biologic agents in a BCG-vaccinated pediatric population

Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies

(2014) Campbell Howard et al.   Cardiovascular Diabetology

How to use: interferon γ release assays for tuberculosis

(2013) Louisa Pollock et al.   Archives of Disease in Childhood-Education and Practice Edition

Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor-  Inhibitors: Systematic Review of the Literature

(2013) S. S. Toussi et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of the Impact of Interferon-Gamma Release Assays on the Management of Childhood Tuberculosis

(2012) Daphne I. Ling et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea

(2011) Boksoon Chang et al.   CLINICAL RHEUMATOLOGY

Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders

(2011) Rachel Smith et al.   CURRENT OPINION IN RHEUMATOLOGY

Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent

(2011) Steffen Hess et al.   EUROPEAN JOURNAL OF PEDIATRICS

Incidence of Tuberculosis Among Korean Patients with Ankylosing Spondylitis Who Are Taking Tumor Necrosis Factor Blockers

(2011) EUN-MI KIM et al.   JOURNAL OF RHEUMATOLOGY

Challenges in Diagnosing Latent Tuberculosis Infection in Patients Treated with Tumor Necrosis Factor Antagonists

(2011) E. C. KEYSTONE et al.   JOURNAL OF RHEUMATOLOGY

Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?

(2011) Omer Kilic et al.   RHEUMATOLOGY INTERNATIONAL

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

Preventing tuberculosis in children receiving anti-tnf treatment

(2010) Nuray Aktay Ayaz et al.   CLINICAL RHEUMATOLOGY

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

(2010) I. Solovic et al.   EUROPEAN RESPIRATORY JOURNAL

TNF-alpha antagonist therapy modify the tuberculin skin test response

(2010) Tulin Cagatay et al.   RHEUMATOLOGY INTERNATIONAL

Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy

(2008) Der-Yuan Chen et al.   ARTHRITIS AND RHEUMATISM

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

(2008) Robert S Wallis   LANCET INFECTIOUS DISEASES